CLINICAL TRIALS PROFILE FOR CHOLIC ACID
✉ Email this page to a colleague
All Clinical Trials for CHOLIC ACID
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00004442 ↗ | Study of Bile Acids in Patients With Peroxisomal Disorders | Terminated | Children's Hospital Medical Center, Cincinnati | N/A | 1969-12-31 | OBJECTIVES: I. Determine the effectiveness of oral bile acid therapy with cholic acid, chenodeoxycholic acid, and ursodeoxycholic acid in patients with peroxisomal disorders involving impaired primary bile acid synthesis. II. Determine whether suppression of synthesis of atypical bile acids and enrichment of bile acid pool with this regimen is effective in treating this patient population and improving quality of life. |
| NCT00004442 ↗ | Study of Bile Acids in Patients With Peroxisomal Disorders | Terminated | University of Cincinnati | N/A | 1969-12-31 | OBJECTIVES: I. Determine the effectiveness of oral bile acid therapy with cholic acid, chenodeoxycholic acid, and ursodeoxycholic acid in patients with peroxisomal disorders involving impaired primary bile acid synthesis. II. Determine whether suppression of synthesis of atypical bile acids and enrichment of bile acid pool with this regimen is effective in treating this patient population and improving quality of life. |
| NCT00007020 ↗ | Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid | Completed | Children's Hospital Medical Center, Cincinnati | Phase 3 | 1992-01-01 | OBJECTIVES: I. To Evaluate the therapeutic efficacy of cholic acid during provision of compassionate treatment to patients with identified inborn errors of bile acid synthesis and metabolism II. To assess the safety and tolerability of cholic acid |
| NCT00007020 ↗ | Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid | Completed | Retrophin, Inc. | Phase 3 | 1992-01-01 | OBJECTIVES: I. To Evaluate the therapeutic efficacy of cholic acid during provision of compassionate treatment to patients with identified inborn errors of bile acid synthesis and metabolism II. To assess the safety and tolerability of cholic acid |
| NCT00007020 ↗ | Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid | Completed | Travere Therapeutics, Inc. | Phase 3 | 1992-01-01 | OBJECTIVES: I. To Evaluate the therapeutic efficacy of cholic acid during provision of compassionate treatment to patients with identified inborn errors of bile acid synthesis and metabolism II. To assess the safety and tolerability of cholic acid |
| NCT00457639 ↗ | Cholic Acid for Hepatic Steatosis in Lipodystrophy | Completed | FDA Office of Orphan Products Development | Phase 2 | 2006-04-01 | To evaluate the efficacy and safety of cholic acid therapy in treating lipodystrophy patients with hepatic steatosis. This is a randomized, double-blind, placebo-controlled cross-over study. |
| NCT00457639 ↗ | Cholic Acid for Hepatic Steatosis in Lipodystrophy | Completed | University of Texas Southwestern Medical Center | Phase 2 | 2006-04-01 | To evaluate the efficacy and safety of cholic acid therapy in treating lipodystrophy patients with hepatic steatosis. This is a randomized, double-blind, placebo-controlled cross-over study. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CHOLIC ACID
Condition Name
Clinical Trial Locations for CHOLIC ACID
Trials by Country
Clinical Trial Progress for CHOLIC ACID
Clinical Trial Phase
Clinical Trial Sponsors for CHOLIC ACID
Sponsor Name
